Palantir Technologies Inc.

🇺🇸NASDAQ Global Select
Back to all articles
Palantir Technologies Inc. stock analysis PLTR overview
Slightly Bullish +25

How Can Palantir Be Down 26% in 2026 When Stocks Are Near All-Time Highs? - 24/7 Wall St.

📉 PLTR shares are down 4% today and roughly 26% year-to-date in 2026, significantly underperforming the S&P 500 which is up 9%.

💰 The company reported Q1 2026 revenue of $1.633 billion, representing an 85% year-over-year increase.

🚀 U.S. commercial revenue specifically surged by 133% in the first quarter of 2026.

📈 Management raised full-year revenue guidance to its largest ever level following the strong Q1 print.

⚖️ The stock trades at a trailing P/E ratio of 155x and a forward P/E of 97x, indicating extreme valuation multiples.

🏦 Morningstar estimates a fair value of $153 but warns of very high uncertainty regarding market size and competition.

⚠️ Specific negative drivers include insider selling, a UK NHS data privacy controversy, and rising competition from OpenAI and Anthropic.

💬 CEO Alex Karp stated the company cannot meet current U.S. demand, citing 100% growth potential in that region.

🎯 The Wall Street consensus price target is $183.73 with 18 Buy ratings and 1 Strong Buy rating.

📅 The next major catalyst is the Q2 2026 earnings report, where management guided revenue between $1.797 billion and $1.801 billion.

🔍 Reddit sentiment on investing subreddits has shifted from bullish to bearish (scores 27-38) in mid-month.

📉 PLTR shares recently fell from $144.45 at filing to $133.79 one day after the earnings print.

Bullish Signals
  • Q1 2026 revenue grew by 85% year-over-year to reach $1.633 billion, demonstrating exceptional top-line expansion.
  • U.S. commercial revenue exploded with a 133% increase, highlighting strong domestic market penetration.
  • Management raised full-year revenue guidance for the largest amount ever in the company's history.
  • CEO Alex Karp confirmed that demand in the U.S. is so high the company cannot meet it, implying significant backlog.
  • The stock achieved a Rule of 40 score of 145, indicating a healthy balance of growth and profitability.
  • Analyst consensus remains bullish with a price target of $183.73 and 18 Buy ratings despite the recent drop.
  • Argus reiterated a bullish stance with a $190 target, framing the current pullback as a potential entry opportunity.
Risk Factors
  • The stock is trading at extreme multiples with a trailing P/E of 155x and a forward P/E of 97x.
  • Morningstar flags very high uncertainty regarding total addressable market estimates and competitive landscape.
  • A UK NHS data privacy controversy has emerged as a specific negative driver for the stock price.
  • Significant insider selling activity is contributing to downward pressure on the share price.
  • Competition from major AI labs like OpenAI and Anthropic poses a threat to Palantir's market position.
  • Retail sentiment has shifted sharply to bearish territory on social platforms following the earnings release.
  • The stock is classified as an 'already run' winner, making it a natural source of funds for rotation into laggards.
Full Analysis
Palantir Technologies (PLTR) shares are trading near $130, down 4% for the day and roughly 26% year-to-date in 2026, creating a stark divergence from the broader market. While the S&P 500 ETF sits near all-time highs with a 9% gain, PLTR remains one of the most prominent large-cap underperformers. Analysts attribute this slide primarily to multiple compression rather than deteriorating fundamentals, noting that the company entered 2026 trading at extreme valuations following a parabolic run in 2025. Despite the stock price decline, Palantir reported robust Q1 2026 results with revenue growth of 85% year-over-year to $1.633 billion. U.S. commercial revenue surged by 133%, and the company achieved a Rule of 40 score of 145. Management subsequently raised its full-year revenue guidance, marking the largest ever increase in that metric. CEO Alex Karp emphasized that demand in the U.S. is so high that the company cannot currently meet it, while CTO Shyam Sankar highlighted the strategic importance of their AIP platform. The negative sentiment surrounding PLTR stems from a combination of valuation concerns and specific headwinds. Morningstar maintains a $153 fair value estimate but flags very high uncertainty regarding total addressable market and competition from AI labs like OpenAI and Anthropic. Additional pressure comes from insider selling, a UK NHS data privacy controversy, and a shift in retail sentiment on social platforms from bullish to bearish as money rotates out of 'already run' winners into laggards. Investors face a classic dispersion scenario where index strength masks underlying pain for specific high-multiple stocks. Even after the drawdown, PLTR trades at a forward P/E ratio of 97x, keeping the valuation debate active. The consensus price target stands at $183.73 with 18 Buy ratings, suggesting potential entry opportunities for bulls who view the pullback as a correction. Prudent investors are advised to monitor whether shares can stabilize above their 52-week low of $118.93 ahead of the anticipated Q2 2026 earnings report.